Lombard Odier Asset Management (Switzerland)’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-76,103
| Closed | -$15.2M | – | 154 |
|
|
2023
Q1 | $15.2M | Buy |
76,103
+19,365
| +34% | +$3.88M | 1.33% | 20 |
|
|
2022
Q4 | $13.5M | Buy |
56,738
+21,125
| +59% | +$5.02M | 1.08% | 34 |
|
|
2022
Q3 | $7.13M | Sell |
35,613
-10,491
| -23% | -$2.1M | 0.6% | 49 |
|
|
2022
Q2 | $6.72M | Sell |
46,104
-36,934
| -44% | -$5.39M | 0.57% | 43 |
|
|
2022
Q1 | $13.6M | Buy |
+83,038
| New | +$13.6M | 1.06% | 37 |
|